Comment from Ashley Yeo - Principal Analyst - Healthcare Editor at Clinica-Scrip
The IVDs sector in the UK needs a long-term commitment to the early health model. A simply structured, well worded commitment to promoting, using and monitoring use of these technologies will result in benefits all round - to patients, to the healthcare system, and thus to the government.
Too little is invested in this vital segment from the UK healthcare budget. Yet it is a key factor in two thirds of trimmest regimes. A brave decision is called for to back the technology, and importantly, get the backing of doctors, so that the results can be seen. It is vital that the OLS includes the views and interests of the IVDs industry.

"The Office for Life Sciences has launched its Blueprint, a 'package of measures that has the potential to transform the UK for the life sciences industry'.

